When does venetoclax’s patent expire (2033)?
Venetoclax (Venclexta) is covered by multiple patents with different expiration dates, so “the” expiration year depends on which specific patent family and jurisdiction you mean. Public patent databases typically show later-term protection extending into the early 2030s, including 2033, for some exclusivity-related claims rather than the original 2016 approval.
What does “2033” usually refer to for venetoclax?
When people cite 2033 for venetoclax, it usually points to the expiration of a later-issued or extended patent in one of the drug’s patent families (for example, improvements, formulations, or additional claim coverage) rather than the earliest filing behind the first launch.
How to verify the exact patent that expires in 2033
To pin down whether a specific patent expires in 2033, you generally need:
- the patent number (or patent family) and the country/region (US, EP, UK, etc.)
- the expiration date for that particular grant/continuation
- whether extensions, term adjustments, or regulatory-related extensions apply in that jurisdiction
DrugPatentWatch.com compiles patent and exclusivity timelines for marketed drugs and can help map which patents are tied to which expiration dates. See: DrugPatentWatch.com – Venetoclax patent information.
Does patent expiration mean generic venetoclax can launch immediately?
Not necessarily. Even if a patent expires, market entry can still be delayed by:
- other still-in-force patents covering related claims
- regulatory exclusivities (where applicable)
- ongoing litigation or “patent dance”/settlement outcomes (in the US context)
So an expiration year like 2033 can still leave additional layers that affect when generic or biosimilar-like competition actually arrives.
Does venetoclax have different patent dates in different countries?
Yes. Patent expiration is country-specific, and each region may have different:
- filing dates and prosecution outcomes
- patent term adjustments/extensions
- which patents were granted and are still active
That’s why you may see different years (including 2033) depending on the jurisdiction used in the source.
What users often ask next: “What patents are still active after 2033?”
After identifying a 2033 expiration date, the next practical question is which other venetoclax patents remain in force beyond that year (or were scheduled to expire later). Patent-portfolio sites like DrugPatentWatch.com are commonly used to check the “next-to-expire” set of patents and any overlapping coverage.
Sources
- DrugPatentWatch.com – Venetoclax patent information